Observer variation in immunohistochemical analysis of protein expression, time for a change?

被引:210
作者
Kirkegaard, T.
Edwards, J.
Tovey, S.
McGlynn, L. M.
Krishna, S. N.
Mukherjee, R.
Tam, L.
Munro, A. F.
Dunne, B.
Bartlett, J. M. S.
机构
[1] Univ Glasgow, Glasgow Royal Infirm, Div Canc Sci & Mol Pathol, Dept Surg,Endocrine Canc Grp,Sect Surg & Translat, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Glasgow, Glasgow Royal Infirm, Dept Pathol, Glasgow G31 2ER, Lanark, Scotland
关键词
diagnostic pathology; immunohistochemistry; interclass correlation coefficient; observer variation; tissue microarrays;
D O I
10.1111/j.1365-2559.2006.02412.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aim: Immunohistochemical analysis of protein expression is central to most clinical translational studies and defines patient treatment or selection criteria for novel drugs. Interobserver variation is rarely analysed despite recognition that this is a key area of potential inaccuracy. Therefore our aim was to examine observer variation and suggest the revision of current standards. Methods and Results: We analysed inter- and intra-observer variation, by interclass correlation coefficient (ICCC) and kappa statistics, in 8661 samples. Intra-observer assessment of nuclear, cytoplasmic and membrane staining for seven proteins in 1323 samples resulted in an ICCC of 0.94 and a kappa-value of 0.787. Interobserver reproducibility, assessed on 28 proteins by seven observer pairs in 8661 carcinomas, gave an ICCC of 0.90 and a kappa-value of 0.70. No significant effect of either antibody or cellular compartmentalization was observed. Conclusion: We have demonstrated that ICCC is a consistent method to assess observer variation when a continuous scoring system is used, compared with kappa statistics, which depends on a categorical system. Given the importance of accurate assessment of protein expression in diagnostic and experimental medicine, we suggest raising thresholds for observer variation: ICCC of 0.7 should be regarded as the minimum acceptable standard, ICCC of 0.8 as good and ICCC of >= 0.9 as excellent.
引用
收藏
页码:787 / 794
页数:8
相关论文
共 39 条
[1]   Comparison of different scoring systems for immunohistochemical staining [J].
Adams, EJ ;
Green, JA ;
Clark, AH ;
Youngson, JH .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (01) :75-77
[2]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[3]   The clinical evaluation of HER-2 status: which test to use? [J].
Bartlett, J ;
Mallon, E ;
Cooke, T .
JOURNAL OF PATHOLOGY, 2003, 199 (04) :411-417
[4]   Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer [J].
Bartlett, JMS ;
Brawley, D ;
Grigor, K ;
Munro, AF ;
Dunne, B ;
Edwards, J .
JOURNAL OF PATHOLOGY, 2005, 205 (04) :522-529
[5]   Evaluating HER2 amplification and overexpression in breast cancer [J].
Bartlett, JMS ;
Going, JJ ;
Mallon, EA ;
Watters, AD ;
Reeves, JR ;
Stanton, P ;
Richmond, J ;
Donald, B ;
Ferrier, R ;
Cooke, TG .
JOURNAL OF PATHOLOGY, 2001, 195 (04) :422-428
[6]  
Birner P, 2001, CLIN CANCER RES, V7, P1669
[7]   Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer [J].
Brown, RSD ;
Edwards, J ;
Dogan, A ;
Payne, H ;
Harland, SJ ;
Bartlett, JMS ;
Masters, JRW .
JOURNAL OF PATHOLOGY, 2002, 198 (02) :237-244
[8]   Estimating the generalized concordance correlation coefficient through variance components [J].
Carrasco, JL ;
Jover, L .
BIOMETRICS, 2003, 59 (04) :849-858
[9]  
CICCHETTI DV, 1981, AM J MENT DEF, V86, P127
[10]   The role of biological markers as predictors of response to preoperative chemotherapy in large primary breast cancer [J].
Cocquyt, VF ;
Schelfhout, VR ;
Blondeel, PN ;
Depypere, HT ;
Daems, KK ;
Serreyn, RF ;
Praet, MM ;
Van Belle, SJP .
MEDICAL ONCOLOGY, 2003, 20 (03) :221-231